- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. Vitiello, A., Ishioka, G., Grey, H.M., Rose, R., Farness, P., LaFond, R., Yuan, L., Chisari, F.V., Furze, J., Bartholomeuz, R. J. Clin. Invest. (1995)